Welcome to C2I, JA Bio Inc.!
The C2I team is excited to announce our new resident company, JA Bio Inc.
JA Bio Inc. is a startup bio-technology company focused on anti-cancer cell immune therapeutics discovery and development.
Their R&D consists of:
→ Tumor immunotherapy industry biomedical research.
→ Anti-cancer immune cells, protein, DNA, and growth factors of drug and technology research and development.
→ Related equipment, reagents process research, and development for licensing and clinic retail.
Their Business activities include:
→ Medical technology development and technical services.
→Technology support & technical consultation.
→ Medical equipment import & export agents allowed by legal licensing distribution.
Learn more about JA Bio Inc. here.